<DOC>
	<DOC>NCT01330563</DOC>
	<brief_summary>The purpose of this study is to assess the effect of Ketoconazole on the pharmacokinetic characteristics of CKD-501 in healthy subject.</brief_summary>
	<brief_title>Drug-drug Interaction Study (CKD-501, Ketoconazole)</brief_title>
	<detailed_description>From day 1 to day 5, Ketoconazole 200mg is administered twice daily to Group 1 patients during period 1. Then on day 5,CKD-501 0.5mg is co-administered Group 1 patients at period 1. After 28 day-break, period 2 will CKD-501 0.5mg administered on day 5. Period 2 will not Ketoconazole administered. Group 2 is administered in reverse order.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Between 20 aged and 45 years old in healthy males 18.5 â‰¤ IBW &lt; 25 Agreement with written informed consent Hypersensitivity reactions to drugs or clinically significant hypersensitivity reactions in the history of party Medication with drugmediated induction/inhibition metabolic enzyme such as Midazolam within 1 month or with may affect the clinical trial Subject has taken abnormal meals which affects the ADME of drug Subject has a history(such as gastric or duodenal ulcer, gastrointestinal surgical histories except for an appendectomy) affects the ADME of drug Substance abuse, or a history of drug abuse showed a positive for the party Continued to be taking caffeine (caffeine &gt; 5 cup/day), drinking (alcohol &gt; 210 g/week) or cannot stop drinking or severe heavy smoker(cigarette &gt; 10 cigarettes per day)during clinical trials Previously participated in other trial within 60 days Previously donate whole blood within 60 days or component blood within 30 days Inadequate subject by medical examination(medical history, physical examination, ECG, laboratory test) within 28 days of starting administration of investigational drug SBP &gt;140 mmHg, SBP &lt; 90 mmHg or DBP &gt; 90 mmHg, DBP &lt; 50 mmHg or Pulse &gt; 100 per/min, Pulse &lt; 50 per/min 12lead ECG, QTc &gt; 450 msec An impossible one who participates in clinical trial by investigator's decision including laboratory test result</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Drug-Drug interaction between the CKD-501 and ketoconazole</keyword>
</DOC>